Literature DB >> 32725926

Reconsidering electrophysiological markers of response inhibition in light of trigger failures in the stop-signal task.

P Skippen1,2, W R Fulham1,2, P T Michie1,2, D Matzke3, A Heathcote4, F Karayanidis1,2,5.   

Abstract

This study investigates the neural correlates underpinning response inhibition using a parametric ex-Gaussian model of stop-signal task performance, fit with hierarchical Bayesian methods, in a large healthy sample (N = 156). The parametric model accounted for both stop-signal reaction time (SSRT) and trigger failure (i.e., failures to initiate the inhibition process). The returned SSRT estimate (SSRTEXG3 ) was attenuated by ≈65 ms compared to traditional nonparametric SSRT estimates (SSRTint ). The amplitude and latency of the N1 and P3 event-related potential components were derived for both stop-success and stop-failure trials and compared to behavioral estimates derived from traditional (SSRTint ) and parametric (SSRTEXG3 , trigger failure) models. Both the fronto-central N1 and P3 peaked earlier and were larger for stop-success than stop-failure trials. For stop-failure trials only, N1 peak latency correlated with both SSRT estimates as well as trigger failure and temporally coincided with SSRTEXG3 , but not SSRTint . In contrast, P3 peak and onset latency were not associated with any behavioral estimates of inhibition for either trial type. While the N1 peaked earlier for stop-success than stop-failure trials, this effect was not found in poor task performers (i.e., high trigger failure/slow SSRT). These findings are consistent with attentional modulation of both the speed and reliability of the inhibition process, but not for poor performers. Together with the absence of any P3 onset latency effect, our findings suggest that attentional mechanisms are important in supporting speeded and reliable inhibition processes required in the stop-signal task.
© 2020 Society for Psychophysiological Research.

Keywords:  Bayesian model; ERP; N100; P300; response inhibition; stop-signal task; trigger failure

Year:  2020        PMID: 32725926     DOI: 10.1111/psyp.13619

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  8 in total

1.  Common and Unique Inhibitory Control Signatures of Action-Stopping and Attentional Capture Suggest That Actions Are Stopped in Two Stages.

Authors:  Joshua R Tatz; Cheol Soh; Jan R Wessel
Journal:  J Neurosci       Date:  2021-09-07       Impact factor: 6.167

2.  Mind Wandering Impedes Response Inhibition by Affecting the Triggering of the Inhibitory Process.

Authors:  Sumitash Jana; Adam R Aron
Journal:  Psychol Sci       Date:  2022-06-14

Review 3.  Partial response electromyography as a marker of action stopping.

Authors:  Liisa Raud; Christina Thunberg; René J Huster
Journal:  Elife       Date:  2022-05-26       Impact factor: 8.713

4.  Dissociation of Medial Frontal β-Bursts and Executive Control.

Authors:  Steven P Errington; Geoffrey F Woodman; Jeffrey D Schall
Journal:  J Neurosci       Date:  2020-10-23       Impact factor: 6.167

5.  Paired-pulse TMS and scalp EEG reveal systematic relationship between inhibitory GABAa signaling in M1 and fronto-central cortical activity during action stopping.

Authors:  Megan Hynd; Cheol Soh; Benjamin O Rangel; Jan R Wessel
Journal:  J Neurophysiol       Date:  2021-01-13       Impact factor: 2.714

6.  Neural correlates of unpredictable Stop and non-Stop cues in overt and imagined execution.

Authors:  Alberto González-Villar; Santiago Galdo-Álvarez; María T Carrillo-de-la-Peña
Journal:  Psychophysiology       Date:  2022-02-27       Impact factor: 4.348

7.  Compromised reactive but intact proactive inhibitory motor control in Tourette disorder.

Authors:  Indrajeet Indrajeet; Cyril Atkinson-Clement; Yulia Worbe; Pierre Pouget; Supriya Ray
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

Review 8.  The Pause-then-Cancel model of human action-stopping: Theoretical considerations and empirical evidence.

Authors:  Darcy A Diesburg; Jan R Wessel
Journal:  Neurosci Biobehav Rev       Date:  2021-07-19       Impact factor: 9.052

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.